19-45890705-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The ENST00000322217.6(MYPOP):āc.1118T>Cā(p.Leu373Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000067 ( 0 hom., cov: 20)
Exomes š: 0.00055 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
MYPOP
ENST00000322217.6 missense
ENST00000322217.6 missense
Scores
1
1
17
Clinical Significance
Conservation
PhyloP100: 1.01
Genes affected
MYPOP (HGNC:20178): (Myb related transcription factor, partner of profilin) Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in negative regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.14468032).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYPOP | NM_001012643.4 | c.1118T>C | p.Leu373Pro | missense_variant | 3/3 | ENST00000322217.6 | NP_001012661.1 | |
MYPOP | XM_047438749.1 | c.*256T>C | 3_prime_UTR_variant | 4/4 | XP_047294705.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYPOP | ENST00000322217.6 | c.1118T>C | p.Leu373Pro | missense_variant | 3/3 | 1 | NM_001012643.4 | ENSP00000325402.4 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 5AN: 74622Hom.: 0 Cov.: 20 FAILED QC
GnomAD3 genomes
AF:
AC:
5
AN:
74622
Hom.:
Cov.:
20
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000301 AC: 5AN: 165888Hom.: 0 AF XY: 0.0000432 AC XY: 4AN XY: 92648
GnomAD3 exomes
AF:
AC:
5
AN:
165888
Hom.:
AF XY:
AC XY:
4
AN XY:
92648
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000547 AC: 273AN: 498658Hom.: 0 Cov.: 23 AF XY: 0.000510 AC XY: 131AN XY: 256940
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
273
AN:
498658
Hom.:
Cov.:
23
AF XY:
AC XY:
131
AN XY:
256940
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000670 AC: 5AN: 74648Hom.: 0 Cov.: 20 AF XY: 0.0000284 AC XY: 1AN XY: 35178
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
5
AN:
74648
Hom.:
Cov.:
20
AF XY:
AC XY:
1
AN XY:
35178
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.1118T>C (p.L373P) alteration is located in exon 3 (coding exon 2) of the MYPOP gene. This alteration results from a T to C substitution at nucleotide position 1118, causing the leucine (L) at amino acid position 373 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
N
PrimateAI
Pathogenic
D
PROVEAN
Benign
N
REVEL
Benign
Sift
Uncertain
D
Sift4G
Benign
T
Polyphen
P
Vest4
MutPred
Gain of glycosylation at L373 (P = 0.0024);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at